Literature DB >> 10619597

Hypertension control: multifactorial contributions.

J M Neutel1, D H Smith.   

Abstract

Treatment of hypertension reduces the risk of several associated deleterious conditions, although it does not lower risk for all cardiovascular diseases. A new theory suggests that high blood pressure is but one piece in the puzzle of a complex syndrome of inherited risk factors called the hypertension syndrome. Several new findings have emerged theorizing that patients may have coronary artery disease before the actual onset of elevated blood pressure. Epidemiologic studies have found that normotensive patients with a family history of hypertension often have a disease process and prognosis similar to that of hypertensives. It seems that some patients may "inherit" abnormalities that make them prone to the development of hypertension, as well as a complex series of cardiovascular disease risk factors. These include elevated lipids, increased left ventricular hypertrophy, arterial stiffening, insulin resistance, renal function abnormalities, and neuroendocrine changes. It is conceivable that the hypertension syndrome may be reversible if the disease process is diagnosed early, which appears to be well before the actual onset of high blood pressure. High blood pressure may be a risk marker for irreversible vascular disease and early detection of the many components of hypertension syndrome may delay or prevent cardiovascular disease from developing in high-risk patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619597     DOI: 10.1016/s0895-7061(99)00221-6

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  3 in total

Review 1.  Metabolic issues in the Antihypertensive and Lipid-Lowering Heart Attack Trial Study.

Authors:  Henry A Punzi; Connie F Punzi
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

2.  Mechanical stretch augments PDGF receptor beta expression and protein tyrosine phosphorylation in pulmonary artery tissue and smooth muscle cells.

Authors:  Y Tanabe; M Saito; A Ueno; M Nakamura; K Takeishi; K Nakayama
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

3.  Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats.

Authors:  Iwona Baranowska; Olga Gawrys; Agnieszka Walkowska; Krzysztof H Olszynski; Luděk Červenka; John R Falck; Adeniyi M Adebesin; John D Imig; Elżbieta Kompanowska-Jezierska
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.